Literature DB >> 9863846

Cost-effectiveness analyses of statistically ineffective treatments.

S Trippoli, A Messori.   

Abstract

Mesh：

Year:  1998        PMID： 9863846     DOI： 10.1001/jama.280.23.1992-a

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

Review 1.  Cost effectiveness of cytotoxic and targeted therapy for metastatic breast cancer: a critical and systematic review.

Authors:  Patricia R Blank; Konstantin J Dedes; Thomas D Szucs
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

2.  Cost-effectiveness of zoledronic acid in the prevention of skeletal-related events in patients with bone metastases secondary to advanced renal cell carcinoma: application to France, Germany, and the United Kingdom.

Authors:  M F Botteman; M Meijboom; I Foley; J M Stephens; Y M Chen; S Kaura
Journal:  Eur J Health Econ       Date:  2010-08-31

3.  Adaptation of a chemosensitivity assay to accurately assess pemetrexed in ex vivo cultures of lung cancer.

Authors:  Sarah L Suchy; Rodney J Landreneau; Matthew J Schuchert; Dakun Wang; Paul R Ervin; Stacey L Brower
Journal:  Cancer Biol Ther       Date:  2012-10-31       Impact factor: 4.742
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.